Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909.

Liu, Hongtao; Johnson, Jeffrey L; Koval, Greg; Malnassy, Greg; Sher, Dorie; Damon, Lloyd E; Hsi, Eric D; Bucci, Donna Marie; Linker, Charles A; Cheson, Bruce D; Stock, Wendy

Liu, Hongtao; Johnson, Jeffrey L; Koval, Greg; Malnassy, Greg; Sher, Dorie; Damon, Lloyd E; Hsi, Eric D; Bucci, Donna Marie; Linker, Charles A; Cheson, Bruce D; Stock, Wendy.

Affiliation

Liu H; University of Chicago Medical Center 5841, S. Maryland Ave, MC2115 Chicago, IL 60637, USA.

Haematologica ; 97(4): 579-85, 2012 Apr.

Article in En | MEDLINE | ID: mdl-22102709

Subject(s)

Immunotherapy; Induction Chemotherapy; Lymphoma, Mantle-Cell/diagnosis; Lymphoma, Mantle-Cell/therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Mantle-Cell/mortality; Middle Aged; Neoplasm, Residual; Prognosis; Survival Analysis; Transplantation, Autologous; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Mantle-Cell / Induction Chemotherapy / Immunotherapy Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Haematologica Year: 2012 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google